Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294584699> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4294584699 abstract "Lenalidomide-based regimens are effective treatment options for patients with relapsed/refractory multiple myeloma (RRMM). However, they are associated with an increased risk of infectious complications. This study examines the clinical factors influencing the occurrence of infection in MM patients treated with lenalidomide and dexamethasone (Rd). A retrospective analysis of all patients who received the Rd regimen between 2017-2021 at our institution was performed. The study group consisted of 174 patients and the median age was 65 years. Most patients (n=110, 63.2%) received the Rd treatment in second-line treatment. The majority of patients (64.3%) received bortezomib-based regimens in the first line of treatment. The median progression-free survival was 12.6 (95% CI: 9.5 – 16.2) months, and the median overall survival was 22.3 (95% CI: 15.9 – 28.6) months. The overall response rate was 64.1%, 12.7% of patients achieved complete response and 20.4% had a very good partial response. In multivariate logistic regression analysis, hypoalbuminemia (OR 4.2, 95%CI:1.6-11.2, p= 0.0039), autologous hematopoietic stem cell transplantation (AHSCT) before Rd (OR 2.6, 95% CI:1.0- 6.7, p= 0.048) and anemia grade ≥3 (OR 5.0, 95%CI: 1.8-14.0, p= 0.002) were independent factors related to the occurrence of infections. In conclusion, in this large cohort of RRMM patients, AHSCT before Rd regimen therapy, hypoalbuminemia and anemia during treatment were identified as three independent factors influencing the frequency of infections during Rd therapy. Patients with established risk factors may benefit from optimal supportive therapy." @default.
- W4294584699 created "2022-09-05" @default.
- W4294584699 creator A5015726868 @default.
- W4294584699 creator A5021873830 @default.
- W4294584699 creator A5040535803 @default.
- W4294584699 creator A5053062200 @default.
- W4294584699 creator A5064484491 @default.
- W4294584699 creator A5087495572 @default.
- W4294584699 creator A5087571749 @default.
- W4294584699 date "2022-09-01" @default.
- W4294584699 modified "2023-10-18" @default.
- W4294584699 title "Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-life Results of a Large Single-center Study" @default.
- W4294584699 doi "https://doi.org/10.20944/preprints202209.0018.v1" @default.
- W4294584699 hasPublicationYear "2022" @default.
- W4294584699 type Work @default.
- W4294584699 citedByCount "0" @default.
- W4294584699 crossrefType "posted-content" @default.
- W4294584699 hasAuthorship W4294584699A5015726868 @default.
- W4294584699 hasAuthorship W4294584699A5021873830 @default.
- W4294584699 hasAuthorship W4294584699A5040535803 @default.
- W4294584699 hasAuthorship W4294584699A5053062200 @default.
- W4294584699 hasAuthorship W4294584699A5064484491 @default.
- W4294584699 hasAuthorship W4294584699A5087495572 @default.
- W4294584699 hasAuthorship W4294584699A5087571749 @default.
- W4294584699 hasBestOaLocation W42945846991 @default.
- W4294584699 hasConcept C126322002 @default.
- W4294584699 hasConcept C141071460 @default.
- W4294584699 hasConcept C2776009029 @default.
- W4294584699 hasConcept C2776063141 @default.
- W4294584699 hasConcept C2776364478 @default.
- W4294584699 hasConcept C2776694085 @default.
- W4294584699 hasConcept C2777063308 @default.
- W4294584699 hasConcept C2777408962 @default.
- W4294584699 hasConcept C2778248108 @default.
- W4294584699 hasConcept C2780401358 @default.
- W4294584699 hasConcept C2781413609 @default.
- W4294584699 hasConcept C2911091166 @default.
- W4294584699 hasConcept C71924100 @default.
- W4294584699 hasConcept C90924648 @default.
- W4294584699 hasConceptScore W4294584699C126322002 @default.
- W4294584699 hasConceptScore W4294584699C141071460 @default.
- W4294584699 hasConceptScore W4294584699C2776009029 @default.
- W4294584699 hasConceptScore W4294584699C2776063141 @default.
- W4294584699 hasConceptScore W4294584699C2776364478 @default.
- W4294584699 hasConceptScore W4294584699C2776694085 @default.
- W4294584699 hasConceptScore W4294584699C2777063308 @default.
- W4294584699 hasConceptScore W4294584699C2777408962 @default.
- W4294584699 hasConceptScore W4294584699C2778248108 @default.
- W4294584699 hasConceptScore W4294584699C2780401358 @default.
- W4294584699 hasConceptScore W4294584699C2781413609 @default.
- W4294584699 hasConceptScore W4294584699C2911091166 @default.
- W4294584699 hasConceptScore W4294584699C71924100 @default.
- W4294584699 hasConceptScore W4294584699C90924648 @default.
- W4294584699 hasLocation W42945846991 @default.
- W4294584699 hasLocation W42945846992 @default.
- W4294584699 hasOpenAccess W4294584699 @default.
- W4294584699 hasPrimaryLocation W42945846991 @default.
- W4294584699 hasRelatedWork W1984362733 @default.
- W4294584699 hasRelatedWork W1998776005 @default.
- W4294584699 hasRelatedWork W2051109119 @default.
- W4294584699 hasRelatedWork W2052790104 @default.
- W4294584699 hasRelatedWork W2083532270 @default.
- W4294584699 hasRelatedWork W2092074428 @default.
- W4294584699 hasRelatedWork W2418365780 @default.
- W4294584699 hasRelatedWork W2980910443 @default.
- W4294584699 hasRelatedWork W3134875278 @default.
- W4294584699 hasRelatedWork W4310127697 @default.
- W4294584699 isParatext "false" @default.
- W4294584699 isRetracted "false" @default.
- W4294584699 workType "article" @default.